Når det besluttes, hvorvidt amning skal fortsætte/ afbrydes eller behandlingen med NeuroBloc skal fortsætte/ afbrydes, bør man opveje fordelen af amning for barnet og fordelen af NeuroBloc behandling for kvinden.
A decision on whether to continue/ discontinue breast-feeding or to continue/ discontinue therapy with NeuroBloc should be made taking into account the benefit of breast-feeding to the child and the benefit of NeuroBloc therapy to the women.